Evidence map›Paper›PMID 33630834›Full record

Trial reportPLoS medicine2021

Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study.

Despoina Manousaki, Adil Harroud, Ruth E Mitchell, Stephanie Ross, Vince Forgetta, Nicholas J Timpson, George Davey Smith, Constantin Polychronakos, J Brent Richards

Erratum issuedOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 72 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 7 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 7 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational epidemiological studies can mitigate genetic confounding with a genetic relatedness matrix.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Review
  15. Vitamin D and Mineral Ion Regulation.Advances in experimental medicine and biology · 2026
    Review
  16. Vitamin DFrontiers in immunology · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Despoina ManousakiDepartment of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.ORCID 0000-0002-4133-0618
Adil HarroudDepartment of Neurology, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0003-2616-7274
Ruth E MitchellMedical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-3506-160X
Stephanie RossDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Vince ForgettaCentre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-6061-4720
Nicholas J TimpsonMedical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-7141-9189
George Davey SmithMedical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-1407-8314
Constantin PolychronakosDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.
J Brent RichardsCentre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-3746-9086
University of Bristol · GBCentre for Interdisciplinary Research in Rehabilitation · CACentre Hospitalier Universitaire Sainte-Justine · CAImpact · CAJewish General Hospital · CAKing's College London · GBUniversity of California, San Francisco · US

Funding

Cancer Research UK C18281/A19169CIHRDepartment of HealthMedical Research Council MC_PC_15018Medical Research Council MC_UU_00011/1Wellcome TrustWellcome Trust 202802/Z/16/ZWellcome Trust 217065/Z/19/Z
6 · The paper itself

Abstract

backgroundVitamin D deficiency has been associated with type 1 diabetes in observational studies, but evidence from randomized controlled trials (RCTs) is lacking. The aim of this study was to test whether genetically decreased vitamin D levels are causally associated with type 1 diabetes using Mendelian randomization (MR). METHODS AND

findingsFor our two-sample MR study, we selected as instruments single nucleotide polymorphisms (SNPs) that are strongly associated with 25-hydroxyvitamin D (25OHD) levels in a large vitamin D genome-wide association study (GWAS) on 443,734 Europeans and obtained their corresponding effect estimates on type 1 diabetes risk from a large meta-analysis of 12 type 1 diabetes GWAS studies (Ntot = 24,063, 9,358 cases, and 15,705 controls). In addition to the main analysis using inverse variance weighted MR, we applied 3 additional methods to control for pleiotropy (MR-Egger, weighted median, and mode-based estimate) and compared the respective MR estimates. We also undertook sensitivity analyses excluding SNPs with potential pleiotropic effects. We identified 69 lead independent common SNPs to be genome-wide significant for 25OHD, explaining 3.1% of the variance in 25OHD levels. MR analyses suggested that a 1 standard deviation (SD) decrease in standardized natural log-transformed 25OHD (corresponding to a 29-nmol/l change in 25OHD levels in vitamin D-insufficient individuals) was not associated with an increase in type 1 diabetes risk (inverse-variance weighted (IVW) MR odds ratio (OR) = 1.09, 95% CI: 0.86 to 1.40, p = 0.48). We obtained similar results using the 3 pleiotropy robust MR methods and in sensitivity analyses excluding SNPs associated with serum lipid levels, body composition, blood traits, and type 2 diabetes. Our findings indicate that decreased vitamin D levels did not have a substantial impact on risk of type 1 diabetes in the populations studied. Study limitations include an inability to exclude the existence of smaller associations and a lack of evidence from non-European populations.

conclusionsOur findings suggest that 25OHD levels are unlikely to have a large effect on risk of type 1 diabetes, but larger MR studies or RCTs are needed to investigate small effects.

Indexed as

Mendelian Randomization AnalysisDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Genome-Wide Association StudyHumansPhenotypePolymorphism, Single NucleotideRisk FactorsVitamin DVitamin D DeficiencyVitamin D

Identifiers

PMID33630834
PMCPMC7906317
OpenAlexW3130928990

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.